ARCHIVES

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Durant To Leave Alabama, Will Become President, Chief Executive Officer At Fox Chase Cancer Center

September 17, 1982

In Brief: Pay raise Must Come From Intramural Funds, Not Extramural, Administration Says

May 9, 1980

New Understanding of drug Resistance Exciting Revolution

September 17, 1982

Without Advance Directives, Families Prolong Treatment

April 27, 2001

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

CMS Dares Critics To Produce ESA Data; House Bill Seeks To Vacate Coverage Decision.

September 28, 2007